| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $1.5B | $1.0B | $1.0B |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| R&D Expense | — | — | — |
| SG&A Expense | — | — | — |
| Operating Income | $0.3B | $0.3B | $-0.5B |
| Net Income | $0.1B | $0.2B | $-0.6B |
| EPS (Basic) | $2.22 | $3.15 | $-11.13 |
| EPS (Diluted) | $2.21 | $3.12 | $-11.13 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $10.6B | $9.2B | $9.6B |
| Current Assets | — | — | — |
| Cash & Equivalents | $1.5B | $0.6B | $0.6B |
| Total Liabilities | $6.8B | $6.4B | $6.5B |
| Current Liabilities | — | — | — |
| Stockholders' Equity | $3.8B | $2.8B | $3.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.4B | $-0.3B |
| Investing Cash Flow | $-0.2B | $-0.3B | $-0.3B |
| Capital Expenditures | — | — | — |
| Financing Cash Flow | $0.9B | $-0.2B | $0.5B |